RVMD stays a Strong Buy as RAS inhibitor trials advance; phase 3 RASolute-302 is a key 2026 catalyst. Read the latest ...

A massive influx of applicants has filed to take advantage of Minnesota’s new paid leave program open to “undocumented ...

The Ghana Shippers’ Authority (GSA) has held a high-level exporters’ forum aimed at strengthening collaboration among ...

Q2 2026 Earnings Call Transcript January 8, 2026 Tilray Brands, Inc. misses on earnings expectations. Reported EPS is $-0.41 ...

Agreement expands Madrigal’s pipeline and strengthens its leadership in pioneering MASH therapiesDGAT-2 inhibition represents a complementary mechanism of action with Rezdiffra® (resmetirom) for ...

Agreement expands Madrigal's pipeline and strengthens its leadership in pioneering MASH therapiesDGAT-2 inhibition represents a complementary mechanism of action with Rezdiffra- (resmetirom) for poten ...

CES® 2026, the most powerful tech event in the world, is wrapping up four days of innovators showing up. The largest ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

In the early Seventies, America looked to be all played out. The postwar industrial boom that powered its golden age of ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

January 08, 2026 - PRESSADVANTAGE - Silverback Webinar has announced continued development and refinement of its ...

Good morning, everyone, and welcome to the ImmuCell Corporation conference call to discuss strategic change in focus and unaudited 2025 sales results. [Operator Instructions] Please also note, today's ...